"What they found was that of all new drugs approved in the last 20 years, 12% came from the SBIR/STTR program," said Jere Glover.
Perion Network Ltd. is rated a Buy with an unchanged price target of $14.75. Learn more about PERI stock here.
For low Earth orbit satellites, the delay is measured in milliseconds. For lunar missions, it stretches into seconds and, for Mars, into minutes. This latency cannot be eliminated, but it can be ...